We are excited to be able to present final videos from this highly anticipated annual event, the 2020 Targeted Therapies Patient Lung Cancer Conference®. In 23rd Annual Winter Lung Cancer Conference®. January 23-25, 2026 · Register now! 27th Annual International Lung Cancer Congress®. Link to Full Transcript: How can lung cancer patients access optimal care? Expert Dr. Christian Rolfo from
Dr. David R. Gandara, MD invites oncologists to attend the 22nd Annual International Lung Cancer Congress® to engage with At the upcoming 23rd Annual International Lung Cancer Congress®, Solange Peters, MD, PhD will be giving two presentation around relevant Listen to the Conference Chairs Discuss Highlights from WCLC 2020. In this live webinar Dr. Yi-long Wu, Dr. Daniel Tan and Dr.
Martin Wermke, MD, University Hospital Carl Gustav Carus, Dresden, Germany, presents his highlights in lung cancer at the Dr. Socinski on why you should attend Winter Lung Cancer Conference
Top 4 Highlights from World Conference on Lung Cancer Annual International Brain Tumor Symposium | Rutgers Cancer
ISPOR 23rd Annual International Meeting "Bridging the Gap": How the National Lung Cancer Audit aims to tackle health inequalities Dr. Carbone Discusses Immunotherapy Studies in Lung Cancer
LUNG CANCER SCREENING: A NEW ERA FOR PATIENTS AT RISK Click here to claim CME/NCPD/CPE credit for this activity: An estimated 236740 new cases of Friends of Cancer Research Annual Meeting 2023
Lung Cancer | Poster abstracts of the 23rd Annual British Thoracic Upcoming CME Events & Activities | Managed Healthcare Executive
Giving a voice to lung cancer Dr. Heather Wakelee invites you to the 23rd Annual International Lung Cancer Conference: July 28-30
ISPOR 23rd Annual International Meeting. Don't Miss the Latest Insights from Syneos Health. Symposium. Monday, 12: Link to Full Transcript: Lung cancer progression can be aided by monitoring of biomarkers, but what do they
Reserve your spot today: Ferdinandos Skoulidis, M.D, Ph.D. discusses Current and Emerging Strategies to Tackle KRAS-Mutant NSCLC at KRAS Kickers Role of Molecular Biology, Evolving Immunotherapy Addressed in
Adjuvant Immunotherapy: Questions/Concerns - Leading Developments & Current Questions in Lung Cancer Beth Zigmund, MD, UVM Associate Professor of Radiology "This educational video is content from the UVM Cancer Center's 23rd Dr. David Gandara invites you to the 23rd Annual International Lung Cancer Congress®
Optimizing Treatment Selection, Sequencing, and Tolerability in Small Cell Lung Cancer Cocktail with science - The best of the year in lung cancer Day 2 Dr. David Gandara - University Of California Davis.
ASCO Daily News 2023 Plenary Update - LBA3: ADAURA IASLC 18th World Conference on Lung Cancer (WCLC 2017) Promo
Genitourinary Cancer (1); Gynecologic Cancer (1); Hematologic Cancer Annual Hematology Meeting: Preceding the 67th ASH Annual Meeting and Alive and Kicking: Current and Emerging Strategies to Tackle KRAS-Mutant NSCLC Providence KATU Family Matters 11/20/20 AMNW: Lung Cancer Screening – Dr. Sanborn
Dr. David R. Gandara, MD Summarizes the The 22nd Annual International Lung Cancer Congress® An information film to promote informed decision-making for a lung cancer screening This educational activity is directed toward medical, surgical, and radiation oncologists involved in the treatment of patients with breast cancer.
How Can I Get the Best Lung Cancer Care? This Symposium on the subject of "Non-Small Cell Lung Cancer: Is It Now Multiple Diseases?" was presented at the 13th Annual
Jorge Nieva, MD, an associate professor of clinical medicine at the Keck School of Medicine of the University of Southern Dr. Gandara on Practice-Changing Studies in Lung Cancer
Discussing Lung ESMO 2022 Highlights - Practice changing studies with Dr. Joshua Reuss, Assistant Professor - Department of Hear why you should join us this year for the IASLC 18th World Conference on Lung Cancer in Yokohama, Japan.
Marta Kauffman, LCFA Board Member and Writer and Exec Producer of Friends and Grace and Frankie, interviews some of the Wistuba, MD. In a presentation at the 23rd Annual International Lung Cancer Congress ®, Wistuba examined a pathologist's approach to
An interview with Dr. Roy Herbst from the Yale School of Medicine on the ADAURA study for the 2023 ASCO Annual Meeting. 11/20/20 KATU Family Matters AMNW segment with Dr. Rachel Sanborn from Providence Cancer Institute in Portland, Oregon,
Eric Singhi, MD, a thoracic medical oncologist at the University of Texas MD Anderson Cancer Center, discusses the significance Opening - Matthew Meyerson & Marco Marra How Can Specific Biomarkers Impact Lung Cancer Progression?
Phase I/II trial of EP0031, a next generation selective RET inhibitor This conference provides a unique opportunity for medical, surgical, and radiation oncologists and other health care professionals to learn from and interact
Dr. Nagashree Seetharamu, lung cancer care expert from Northwell Health, reviews takeaways from the Pooled Analysis Dr. Christine Lovly on why it is important to get lung cancer researchers together with lung cancer patients to discuss new RET fusions occur in various cancers, and resistance to selpercatinib and pralsetinib, current first generation selective RET
Lung cancer at ASCO 2023: ADAURA and ADCs The 8th Annual Cancer Disparities Symposium - April 23, 2021
IASLC Webinar: World Conference on Lung Cancer 2020 Highlights Cancer patients face many challenges - but there is also a lot of good news. That was the message in Houston, Texas recently,
The International Association for the Study of Lung Cancer (IASLC) is the only global network dedicated to the study and eradication of lung cancer and The 1st Annual International Brain Tumor Symposium is supported in part by the New Jersey Pediatric Hematology Oncology Research Center of Excellence (NJ PHORCE) Tumor Treating Fields for Lung Cancer - Leading Developments & Current Questions in Lung Cancer
In-Person & Hybrid Events - PER Join Drs Roy S. Herbst, David R. Gandara, and Heather A. Wakelee at the 23rd Annual International Lung Cancer Congress® in
25th Annual International Congress on the Future of Breast Cancer Thank you for making breakthroughs happen. See how far we've come this year. Together we are beating cancer. Find out more:
23rd Annual International Congress on the Future of Breast Cancer Pathology Expert Unpacks the Future Role MPR and pCR in
Jennifer C. King, PhD, Director of Science and Research, shares the top key takeaways from the 19th Annual World Conference Non-Small Cell Lung Cancer: Is It Now Multiple Diseases? Facing end-of-life decisions as a clinical team
Before the IASLC 19th World Conference on Lung Cancer (#WCLC2018) begins, hear from the IASLC's CEO, Dr. Fred R. Hirsch, Why the IASLC World Conference on Lung Cancer (WCLC) is Unique As lung cancer screening is a relatively new area, particularly to non-healthcare professionals, understanding of the procedure
Roy S. Herbst, MD, PhD, invites you to the 23rd Annual International Lung Cancer Congress® Cancer Survivors Find Information, Encouragement at Houston Conference Dr. Singhi on the Significance of the IASLC 2024 World Conference on Lung Cancer
Neal Navani, MA, MRCP, MSc, PhD, University College London Hospitals NHS Foundation Trust, London, UK, discusses a recent Treatment for Patients with EGFR+ NSCLC - Leading Developments & Current Questions in Lung Cancer May 12, 2014 - The Cancer Genome Atlas 3rd Annual Scientific Symposium More:
Josephine Louella Feliciano, MD, assistant professor of oncology, Johns Hopkins Medicine, discusses ROS1-targeted therapy in IASLC | International Association for the Study of Lung Cancer Dr. Heather Wakelee shares her experience from the annual International Lung Cancer Congress®
Lung Cancer Living Room - Personalized Cancer Care Circa 2019 w/ Dr. Gandara - 10/15/19 - Full 2-hr ICAHO20 - ASCO Direct™ Highlights - Dr. Jack West - Non-Small Cell Lung Cancer David Hui, MD, MSc of MD Anderson Cancer Center, Houston, TX discusses end-of-life decisions faced by a clinical team.
Cancer Therapies for Ultra-Rare Indications: Presentation from AACR Annual Meeting, April 11, 2022 Dr Nieva on the Rationale for Comparing ALK Inhibitors in ALK+ NSCLC David R. Gandara, MD, director, Thoracic Oncology Program, professor, senior advisor to director, UC Davis Comprehensive
Join Dr. Wakelee and other experts during the 23rd Annual International Lung Cancer Congress® on July 28 - 30. Learn more at: Join Dr. Gandara and other renowned experts in lung cancer on July 28 - 30, 2022 for the 23rd Annual International Lung Cancer
In this session, Dr Tejas Patil from University of Colorado provides lung cancer updates. Christian Rolfo, MD, PhD, MBA, The Tisch Cancer Institute at Mount Sinai, New York, NY, discusses the role of liquid biopsies in
Observing lung cancer progression with liquid biopsies 2020 TTF EGFR Breakout PIOTROWSKA Part 1 - Current Options Upon Acquired Resistance to Osimertinib
Roy S. Herbst, MD, PhD, invites you to the 23rd Annual International Lung Cancer Congress® July 28 - July 30, 2022. Join PER® Dr. Jack West from the City of Hope discusses ASCO Updates in Non-Small Cell Lung Cancer at ICAHO20 - an officially licensed
For this year's post-ASCO Lung Cancer panel discussion, Drs. H.Jack West, Oncologist with City of Hope Comprehensive Cancer Pooled Analysis Chemo+IO vs. IO in PDL1 High Cohort | Nagashree Seetharamu, MD | ASCO22 Lung Updates
Dr. David Carbone, of The Ohio State University James Cancer Center, discusses EGFR+ Lung Cancer: What is EGFR? Dr Christine Lovly Why Patient Interaction is so important
Dr. Feliciano on ROS1-Targeted Therapy in NSCLC Dr David Carbone on EGFR+ Lung Cancer
David Carbone, MD, PhD, director, James Thoracic Center, Ohio State University Comprehensive Cancer Center, discusses two Friends of Cancer Research Annual Meeting 2023 0:00 - Stream Starts 04:40 - Meeting Begins 07:05 - Opening Keynote
Dana-Farber Cancer Institute's Dr. Christopher Lathan and Dana-Farber/Harvard Cancer Center's Karen Burns White hosted the Heather A. Wakelee, MD, invites you to the 23rd Annual International Lung Cancer Congress® July 28 - July 30, 2022. Join PER®
Poster abstracts of the 23rd Annual British Thoracic Oncology Group Conference 2025. 3-5 March 2025 • ICC Belfast • Publication of this Abstract Book is 2023 Oncology Nursing Society Metro Denver Chapter Conference - Lung Cancer Update Lung ESMO 2022 Highlights - OncBrothers (Rohit and Rahul Gosain) with Dr. Joshua Reuss
Lung cancer treatment is rapidly evolving. The special edition of the Conference "The best of the year in lung cancer " will provide Treatment for Patients with Advanced NSCLC - Leading Developments & Current Questions in Lung Cancer Annual Supporter Update 22/23 | Cancer Research UK